Agios Pharmaceuticals, Inc. (AGIO) vs AxoGen, Inc. (AXGN)
A side-by-side comparison of Agios Pharmaceuticals, Inc. and AxoGen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AGIO
Agios Pharmaceuticals, Inc.
$31.76HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
AXGN
AxoGen, Inc.
$36.52HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — AGIO vs AXGN
growth of $100 · dividends reinvested · last 10yAGIO -41.9% (-5.3%/yr)AXGN +332.8% (+15.8%/yr)AXGN compounded faster over this window
Log scale — wide-divergence pair
AGIO AXGN
AGIO vs AXGN: by the numbers
- •AXGN is the larger company ($1.96B vs $1.90B market cap).
- •Both run net losses; AXGN's is the smaller (-13.36% vs -418.24% net margin).
- •AXGN grew revenue faster over the past five years (13.99% vs 4.54% CAGR).
Metrics side by side
Valuation
| Metric | AGIO | AXGN |
|---|---|---|
| Forward P/E | N/A | 82.53 |
| P/S ratio | 19.28 | 7.82 |
| P/B ratio | 1.85 | 7.66 |
| FCF yield | N/A | 0.13% |
Profitability
| Metric | AGIO | AXGN |
|---|---|---|
| Gross margin | 78.67% | 74.56% |
| Operating margin | -873.87% | -5.12% |
| Net margin | -418.24% | -13.36% |
| ROE | -40.09% | -13.09% |
| ROIC | -44.21% | -4.68% |
Growth (annualized)
| Metric | AGIO | AXGN |
|---|---|---|
| Revenue CAGR (5Y) | 4.54% | 13.99% |
| Total return CAGR (5Y) | -6.59% | 19.40% |
Frequently asked
- Which has grown faster, AGIO or AXGN?
- Over the past five years, AXGN grew revenue faster — AGIO at a 4.54% CAGR versus AXGN at 13.99%.
- How have AGIO and AXGN total returns compared?
- Over the past 10 years, AGIO delivered -5.39% and AXGN delivered 15.98% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Agios Pharmaceuticals ROEAxoGen ROEAgios Pharmaceuticals operating marginAxoGen operating marginAgios Pharmaceuticals revenue growthAxoGen revenue growthAgios Pharmaceuticals free cash flowAxoGen free cash flow
Agios Pharmaceuticals & AxoGen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.